Aquatic Capital Management’s TG Therapeutics TGTX Stock Holding History

Aquatic Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.63M	Buy	79,090 +35,850	+83%	+$1.07M	0.08%	318
2025 Q4	$1.29M	Sell	43,240 -32,248	-43%	-$1.05M	0.04%	484
2025 Q3	$2.73M	Buy	+75,488	New	+$2.49M	0.05%	414
2024 Q4	–	Sell	-51,900	Closed	-$1.21M	–	1608
2024 Q3	$1.21M	Buy	+51,900	New	+$1.13M	0.03%	464
2024 Q2	–	Sell	-191,900	Closed	-$2.92M	–	1596
2024 Q1	$2.92M	Buy	191,900 +180,600	+1,598%	+$2.88M	0.1%	198
2023 Q4	$193K	Sell	11,300 -3,500	-24%	-$40.7K	﹤0.01%	858
2023 Q3	$124K	Buy	+14,800	New	+$206K	0.01%	779
2023 Q2	–	Sell	-20,800	Closed	-$313K	–	1741
2023 Q1	$313K	Buy	+20,800	New	+$316K	0.02%	503
2022 Q4	–	Sell	-3,000	Closed	-$18K	–	1817
2022 Q3	$18K	Sell	3,000 -400	-12%	-$2.62K	﹤0.01%	1005
2022 Q2	$14K	Buy	3,400 +1,500	+79%	+$9.37K	﹤0.01%	911
2022 Q1	$18K	Buy	+1,900	New	+$22K	0.03%	523

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Aquatic Capital Management's TGTX Position: Q1 2026 in Review

Aquatic Capital Management increased its TG Therapeutics (TGTX) stake by 83% in Q1 2026, buying an estimated $1.07M and bringing the position to 79,090 shares worth $2.63M. The position accounts for 0.08% of the portfolio, ranked #318.

Aquatic Capital Management first reported a position in TGTX in Q1 2022 and has held it in 11 quarters since. The position peaked at $2.92M in Q1 2024. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

Aquatic Capital Management held 79,090 shares of TG Therapeutics worth $2.63M as of Q1 2026.
Aquatic Capital Management bought 35,850 TG Therapeutics shares in Q1 2026, an estimated $1.07M.
TG Therapeutics made up 0.08% of Aquatic Capital Management's portfolio in Q1 2026, its #318 holding.
Aquatic Capital Management first reported a position in TG Therapeutics in Q1 2022 and has held it in 11 quarters since.
Aquatic Capital Management's TG Therapeutics position peaked at $2.92M in Q1 2024.
363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.